Table 1.
Electrode modification | Method | Linear range (μM) | Detection limit (μM) | Concomitant compound | Ref |
---|---|---|---|---|---|
Hematoxylin | DPV | 0.5–65.4 65.4–274.2 |
0.14 | AC | [1] |
Graphene modified Pd | DPV | 0.5–500.0 | 0.067 | UA | [2] |
Lt/fMWCNT/MGCE | DPV | 0.7–100.0 | 0.53 | AC, XN, CF | [29] |
Graphene–GCE | CV | 0.6–120.0 | 0.40 | AD, UA, AA | [30] |
C-Ni/GCE | DPV | 0.2–80 | 0.06 | – | [31] |
Poly-CCA-GCE | DPV | 0.63–62.5 | 0.1 AA, UA | [32] | |
Poly(glutamic acid) | CV | 51.0–344 | 0.43 | AA, UA | [33] |
Tetrakis-(2-aminopheny)porphyrin | CV | 1.0–7.0 7.0–50.0 |
— | AA | [34] |
Poly(1,5-diaminonaphthalene) | DPV | 9.90–90.9 | 1.82 | — | [35] |
DSNPs-GCE | DPV | 1.4–26.4 26.4–166.7 166.7–833.3 |
0.4 | AA, UA, Trp | This work |
AC = acetaminophen; AD = adrenaline; CF = caffeine; C-Ni/GCE = carbon-coated nickel magnetic nanoparticles modified glassy carbon electrode; CV = cyclic voltammetry; DPV = differential pulse voltammetry; DSNPs-GCE = delphinidin silver nanoparticles modified glassy carbon electrode; Lt/fMWCNT/MGCE = luteolin on a functionalized multiwall carbon nanotube immobilized on the surface of a glassy carbon electrode; Pd = palladium; poly-CCA-GCE = polycalconcarboxylic acid modified glassy carbon electrode; XN = xanthine.